论文部分内容阅读
目的:探讨液基薄层细胞学(TCT或LCT)检测在宫颈病变中的临床应用价值。方法:对669例宫颈病变患者进行宫颈刮片TCT细胞病理学检查,诊断标准采用TBS分类系统。结果:669例患者TCT检测阳性71例,阳性率10.61%;高度鳞状上皮内病变(HSIL)9例,其中3例为原位癌(CINⅢ);低度鳞状上皮内病变(LSIL)51例,不典型鳞状上皮细胞(ASC)11例。结论:TCT检测用于宫颈病变筛查,可提供早期宫颈癌变和癌前病变的信息。
Objective: To investigate the clinical value of liquid-based thin-layer cytology (TCT or LCT) detection in cervical lesions. Methods: The cervical smear TCT cytopathology was performed in 669 cases of cervical lesions. The diagnostic criteria were TBS classification system. Results: The positive rate of TCT was 71 cases in 669 patients, the positive rate was 10.61%. There were 9 cases of high grade squamous intraepithelial lesion (HSIL), of which 3 cases were in situ carcinoma (CINⅢ) and low grade squamous intraepithelial lesion (LSIL) Cases, atypical squamous epithelial cells (ASC) in 11 cases. CONCLUSIONS: The TCT test is used to screen for cervical lesions and provides information on early cervical cancers and precancerous lesions.